Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Adicionar filtros








Intervalo de ano
1.
Iranian Journal of Cancer Prevention. 2011; 4 (1): 10-14
em Inglês | IMEMR | ID: emr-145125

RESUMO

During radiotherapy treatment, critical organs are shielded using lead and cerrobend blocks. The objective of this study is to compare the effects of lead and cerrobend shielding blocks on incident photon beam. Collimator scatter factors were measured for open square fields [3 x 3 cm to 40 x 40 cm] defined by collimator jaws and for fields blocked down to smaller asymmetric fields by using five different Lead and Cerrobend blocks for 6 and 15 MV photon beams from a Varian Clinac 2100C accelerator. The measurements in air were performed using Farmer type ionization chamber fitted with acrylic build up caps. The Block Tray Factor [BTF] increased with field size for both 6 and 15 MV photon beams. In case of Lead blocks, the extreme variations in BTF for 6 MV photon beam are 0.70%, 0.84%, 0.56%, 0.80% and 1.15%. Similarly, for 15 MV the maximum variations for Lead blocks are 0.46%, 0.60%, 0.83%, 0.88% and 1.10% respectively. No significant difference has been observed in the BTF of Cerrobend blocks for 6 and 15 MV photon beams. The dose received by a point in air apparently shielded by lead blocks has three main contributions: 1. Due to primary photon beam transmitted through the block, 2. Due to scattered photons, 3. Due to contamination electrons. These three factors collectively cause the increase in BTF with increasing field size, energy, and decreasing block size. The effect of shielding on the beam output increases with field size, beam energy and shield size. This increase follows almost the same pattern for both lead and cerrobend shielding blocks. Therefore shield factors for all field sizes, beam energies and shield sizes should be determined separately for precise patient dose delivery


Assuntos
Radioterapia/efeitos adversos , Dosagem Radioterapêutica , Chumbo , Fótons
3.
JMS-Journal of Medical Sciences. 1993; 3 (3): 23-4
em Inglês | IMEMR | ID: emr-28287
4.
JMS-Journal of Medical Sciences. 1991; 1 (3): 19-20
em Inglês | IMEMR | ID: emr-20196
5.
JMS-Journal of Medical Sciences. 1990; 1 (2): 29-30
em Inglês | IMEMR | ID: emr-16375

RESUMO

We are discussing a patient who was initially diagnosed and treated as pulmonary tuberculosis, but on follow up the clinical, radiological features and investigations were highly suggestive of pulmonary vasculitis. Pulmonary vasculitis occurs in a number of conditions including polyarteritis nodosa, SLE, and Wegener's granulomatosis. This can be the sole manifestation of these diseases for months to years before other systemic manifestations appear


Assuntos
Relatos de Casos
6.
Bulletin of the Ophthalmological Society of Egypt. 1982; 75 (79): 145-150
em Inglês | IMEMR | ID: emr-1663

RESUMO

The behavior of platelets aggregation has been studied in diabetics with retinopathy compared to diabetics without retinopathy and normal control groups. It has been found that there is significant increase in A.D.P. platelet aggregation% and V-max. In patient with diabetic retinopathy. The use of drugs which inhibit platelet aggregation could have important therapeutic value in prevention of diabetic retinopathy


Assuntos
Agregação Plaquetária
7.
Bulletin of the Ophthalmological Society of Egypt. 1982; 75 (79): 151-154
em Inglês | IMEMR | ID: emr-1664

RESUMO

Total serum lipids were estimated in diabetics with and without retinopathy compared to normal non-diabetic subjects. It has been found that diabetic patients with retinopathy had significantly higher total serum lipids than diabetic patients Without retinopathy and normal control subjects. This finding supports the view that total serum lipids plays an important role in diabetic retinopathy especially exudative lesions. It also explains the value of drugs or low- fat diet which decrease the serum lipids


Assuntos
Hiperlipidemias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA